Annual Shareholders Equity
$184.02 M
+$133.71 M+265.80%
31 December 2023
Summary:
Spyre Therapeutics annual stockholders equity is currently $184.02 million, with the most recent change of +$133.71 million (+265.80%) on 31 December 2023. During the last 3 years, it has risen by +$100.08 million (+119.22%). SYRE annual shareholders equity is now at all-time high.SYRE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$327.39 M
-$46.99 M-12.55%
30 September 2024
Summary:
Spyre Therapeutics quarterly stockholders equity is currently $327.39 million, with the most recent change of -$46.99 million (-12.55%) on 30 September 2024. Over the past year, it has increased by +$572.79 million (+233.41%). SYRE quarterly shareholders equity is now -12.55% below its all-time high of $374.38 million, reached on 30 June 2024.SYRE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +265.8% | +233.4% |
| 3 y3 years | +119.2% | +290.0% |
| 5 y5 years | +206.3% | +444.9% |
SYRE Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +265.8% | -12.6% | +233.4% |
| 5 y | 5 years | at high | +265.8% | -12.6% | +233.4% |
| alltime | all time | at high | +9729.9% | -12.6% | +233.4% |
Spyre Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $327.39 M(-12.6%) |
| June 2024 | - | $374.38 M(+145.9%) |
| Mar 2024 | - | $152.27 M(-17.3%) |
| Dec 2023 | $184.02 M(+265.8%) | $184.02 M(-175.0%) |
| Sept 2023 | - | -$245.40 M(+18.3%) |
| June 2023 | - | -$207.37 M(-716.2%) |
| Mar 2023 | - | $33.65 M(-33.1%) |
| Dec 2022 | $50.30 M(-40.1%) | - |
| Dec 2022 | - | $50.30 M(-25.5%) |
| Sept 2022 | - | $67.56 M(-19.7%) |
| June 2022 | - | $84.16 M(+36.5%) |
| Mar 2022 | - | $61.66 M(-26.5%) |
| Dec 2021 | $83.94 M(-40.0%) | $83.94 M(-17.8%) |
| Sept 2021 | - | $102.08 M(-14.2%) |
| June 2021 | - | $119.02 M(-3.8%) |
| Mar 2021 | - | $123.75 M(-11.5%) |
| Dec 2020 | $139.83 M(+132.7%) | $139.83 M(+2.6%) |
| Sept 2020 | - | $136.27 M(-10.5%) |
| June 2020 | - | $152.26 M(+255.7%) |
| Mar 2020 | - | $42.80 M(-28.8%) |
| Dec 2019 | $60.08 M | $60.08 M(-24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $79.80 M(-19.9%) |
| June 2019 | - | $99.61 M(-14.3%) |
| Mar 2019 | - | $116.29 M(+72.5%) |
| Dec 2018 | $67.43 M(+34.0%) | $67.43 M(+5.9%) |
| Sept 2018 | - | $63.68 M(-13.3%) |
| June 2018 | - | $73.45 M(+67.2%) |
| Mar 2018 | - | $43.92 M(-12.7%) |
| Dec 2017 | $50.34 M(-20.1%) | $50.34 M(-9.3%) |
| Sept 2017 | - | $55.51 M(-11.3%) |
| June 2017 | - | $62.60 M(+9.5%) |
| Mar 2017 | - | $57.18 M(-9.2%) |
| Dec 2016 | $62.97 M(+74.4%) | $62.97 M(-7.7%) |
| Sept 2016 | - | $68.20 M(-7.7%) |
| June 2016 | - | $73.92 M(+133.2%) |
| Mar 2016 | - | $31.70 M(-12.2%) |
| Dec 2015 | $36.10 M(+1828.6%) | $36.10 M(-8.9%) |
| Sept 2015 | - | $39.65 M(-7.6%) |
| June 2015 | - | $42.90 M(-0.5%) |
| Mar 2015 | - | $43.12 M(+2203.4%) |
| Dec 2014 | $1.87 M(-41.2%) | $1.87 M |
| Dec 2013 | $3.19 M | - |
FAQ
- What is Spyre Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Spyre Therapeutics?
- What is Spyre Therapeutics annual shareholders equity year-on-year change?
- What is Spyre Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly shareholders equity year-on-year change?
What is Spyre Therapeutics annual stockholders equity?
The current annual shareholders equity of SYRE is $184.02 M
What is the all time high annual shareholders equity for Spyre Therapeutics?
Spyre Therapeutics all-time high annual stockholders equity is $184.02 M
What is Spyre Therapeutics annual shareholders equity year-on-year change?
Over the past year, SYRE annual stockholders equity has changed by +$133.71 M (+265.80%)
What is Spyre Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SYRE is $327.39 M
What is the all time high quarterly shareholders equity for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly stockholders equity is $374.38 M
What is Spyre Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, SYRE quarterly stockholders equity has changed by +$572.79 M (+233.41%)